Quantifying the direct secondary health care cost of seasonal influenza in England.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
29 Sep 2020
Historique:
received: 31 03 2020
accepted: 16 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 21 10 2020
Statut: epublish

Résumé

The winter pressure often experienced by NHS hospitals in England is considerably contributed to by severe cases of seasonal influenza resulting in hospitalisation. The prevention planning and commissioning of the influenza vaccination programme in the UK does not always involve those who control the hospital budget. The objective of this study was to describe the direct medical costs of secondary care influenza-related hospital admissions across different age groups in England during two consecutive influenza seasons. The number of hospital admissions, length of stay, and associated costs were quantified as well as determining the primary costs of influenza-related hospitalisations. Data were extracted from the Hospital Episode Statistics (HES) database between September 2017 to March 2018 and September 2018 to March 2019 in order to incorporate the annual influenza seasons. The use of international classification of disease (ICD)-10 codes were used to identify relevant influenza hospitalisations. Healthcare Resource Group (HRG) codes were used to determine the costs of influenza-related hospitalisations. During the 2017/18 and 2018/19 seasons there were 46,215 and 39,670 influenza-related hospital admissions respectively. This resulted in a hospital cost of £128,153,810 and £99,565,310 across both seasons. Results showed that those in the 65+ year group were associated with the highest hospitalisation costs and proportion of in-hospital deaths. In both influenza seasons, the HRG code WJ06 (Sepsis without Interventions) was found to be associated with the longest average length of stay and cost per admission, whereas PD14 (Paediatric Lower Respiratory Tract Disorders without Acute Bronchiolitis) had the shortest length of stay. This study has shown that influenza-related hospital admissions had a considerable impact on the secondary healthcare system during the 2017/18 and 2018/19 influenza seasons, before taking into account its impact on primary health care.

Sections du résumé

BACKGROUND BACKGROUND
The winter pressure often experienced by NHS hospitals in England is considerably contributed to by severe cases of seasonal influenza resulting in hospitalisation. The prevention planning and commissioning of the influenza vaccination programme in the UK does not always involve those who control the hospital budget. The objective of this study was to describe the direct medical costs of secondary care influenza-related hospital admissions across different age groups in England during two consecutive influenza seasons.
METHODS METHODS
The number of hospital admissions, length of stay, and associated costs were quantified as well as determining the primary costs of influenza-related hospitalisations. Data were extracted from the Hospital Episode Statistics (HES) database between September 2017 to March 2018 and September 2018 to March 2019 in order to incorporate the annual influenza seasons. The use of international classification of disease (ICD)-10 codes were used to identify relevant influenza hospitalisations. Healthcare Resource Group (HRG) codes were used to determine the costs of influenza-related hospitalisations.
RESULTS RESULTS
During the 2017/18 and 2018/19 seasons there were 46,215 and 39,670 influenza-related hospital admissions respectively. This resulted in a hospital cost of £128,153,810 and £99,565,310 across both seasons. Results showed that those in the 65+ year group were associated with the highest hospitalisation costs and proportion of in-hospital deaths. In both influenza seasons, the HRG code WJ06 (Sepsis without Interventions) was found to be associated with the longest average length of stay and cost per admission, whereas PD14 (Paediatric Lower Respiratory Tract Disorders without Acute Bronchiolitis) had the shortest length of stay.
CONCLUSION CONCLUSIONS
This study has shown that influenza-related hospital admissions had a considerable impact on the secondary healthcare system during the 2017/18 and 2018/19 influenza seasons, before taking into account its impact on primary health care.

Identifiants

pubmed: 32993588
doi: 10.1186/s12889-020-09553-0
pii: 10.1186/s12889-020-09553-0
pmc: PMC7526100
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1464

Références

J Infect. 2007 Jun;54(6):530-8
pubmed: 17097147
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Ann N Y Acad Sci. 2014 Sep;1323:115-39
pubmed: 24891213
Lancet Infect Dis. 2009 Oct;9(10):601-10
pubmed: 19778762
Proc Am Thorac Soc. 2004;1(2):115-20
pubmed: 16113423
Commun Dis Public Health. 2003 Sep;6(3):231-7
pubmed: 14708274
PLoS One. 2018 Sep 7;13(9):e0202787
pubmed: 30192781
J Infect Dis. 2012 Dec 1;206(11):1652-9
pubmed: 23048170
Curr Epidemiol Rep. 2018;5(1):1-9
pubmed: 29503792
BMC Public Health. 2016 Jun 08;16:481
pubmed: 27278794
Nat Rev Microbiol. 2018 Jan;16(1):60
pubmed: 29109554
BMJ. 1993 Oct 16;307(6910):982-6
pubmed: 8241910
BMJ. 1995 May 13;310(6989):1225-9
pubmed: 7767192
J Infect. 2014 Apr;68(4):363-71
pubmed: 24291062
PLoS One. 2013 Dec 11;8(12):e79360
pubmed: 24348993

Auteurs

Joe W E Moss (JWE)

York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York, YO10 5NQ, UK. joe.moss@york.ac.uk.

Craig Davidson (C)

Sanofi Pasteur UK & Ireland, Reading, UK.

Richard Mattock (R)

York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York, YO10 5NQ, UK.

Ilana Gibbons (I)

Sanofi Pasteur UK & Ireland, Reading, UK.

Stuart Mealing (S)

York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York, YO10 5NQ, UK.

Stuart Carroll (S)

Sanofi Pasteur UK & Ireland, Reading, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH